nodes	percent_of_prediction	percent_of_DWPC	metapath
Ingenol Mebutate—PRKCD—hypertension	0.401	0.569	CbGaD
Ingenol Mebutate—PRKCA—hypertension	0.304	0.431	CbGaD
Ingenol Mebutate—PRKCA—nephron—hypertension	0.00725	0.147	CbGeAlD
Ingenol Mebutate—Application site erosion—Clonidine—hypertension	0.00708	0.0938	CcSEcCtD
Ingenol Mebutate—PRKCA—artery—hypertension	0.00405	0.082	CbGeAlD
Ingenol Mebutate—PRKCA—endothelium—hypertension	0.00342	0.0693	CbGeAlD
Ingenol Mebutate—PRKCA—blood vessel—hypertension	0.00315	0.0639	CbGeAlD
Ingenol Mebutate—PRKCD—adrenal cortex—hypertension	0.0028	0.0566	CbGeAlD
Ingenol Mebutate—PRKCD—heart—hypertension	0.0027	0.0548	CbGeAlD
Ingenol Mebutate—PRKCD—decidua—hypertension	0.00263	0.0533	CbGeAlD
Ingenol Mebutate—PRKCD—cortex of kidney—hypertension	0.00243	0.0493	CbGeAlD
Ingenol Mebutate—PRKCA—myocardium—hypertension	0.00214	0.0433	CbGeAlD
Ingenol Mebutate—Application site burn—Clonidine—hypertension	0.00203	0.027	CcSEcCtD
Ingenol Mebutate—PRKCD—adrenal gland—hypertension	0.00202	0.0409	CbGeAlD
Ingenol Mebutate—Application site erythema—Clonidine—hypertension	0.00181	0.024	CcSEcCtD
Ingenol Mebutate—PRKCD—endocrine gland—hypertension	0.00175	0.0355	CbGeAlD
Ingenol Mebutate—Instillation site pain—Guanabenz—hypertension	0.00174	0.0231	CcSEcCtD
Ingenol Mebutate—PRKCA—brainstem—hypertension	0.00172	0.0349	CbGeAlD
Ingenol Mebutate—PRKCD—central nervous system—hypertension	0.00158	0.032	CbGeAlD
Ingenol Mebutate—PRKCA—nephron tubule—hypertension	0.00157	0.0317	CbGeAlD
Ingenol Mebutate—PRKCA—heart—hypertension	0.00149	0.0302	CbGeAlD
Ingenol Mebutate—PRKCA—smooth muscle tissue—hypertension	0.00148	0.03	CbGeAlD
Ingenol Mebutate—PRKCA—decidua—hypertension	0.00145	0.0294	CbGeAlD
Ingenol Mebutate—Periorbital oedema—Guanabenz—hypertension	0.00144	0.0191	CcSEcCtD
Ingenol Mebutate—PRKCA—cardiovascular system—hypertension	0.00141	0.0285	CbGeAlD
Ingenol Mebutate—PRKCA—kidney—hypertension	0.00138	0.0279	CbGeAlD
Ingenol Mebutate—Instillation site pain—Clonidine—hypertension	0.00131	0.0173	CcSEcCtD
Ingenol Mebutate—Periorbital oedema—Diltiazem—hypertension	0.00128	0.0169	CcSEcCtD
Ingenol Mebutate—Periorbital oedema—Nifedipine—hypertension	0.00122	0.0162	CcSEcCtD
Ingenol Mebutate—Instillation site pain—Furosemide—hypertension	0.00115	0.0152	CcSEcCtD
Ingenol Mebutate—PRKCA—adrenal gland—hypertension	0.00111	0.0225	CbGeAlD
Ingenol Mebutate—Application site pain—Clonidine—hypertension	0.000969	0.0128	CcSEcCtD
Ingenol Mebutate—PRKCA—endocrine gland—hypertension	0.000965	0.0195	CbGeAlD
Ingenol Mebutate—Scab—Timolol—hypertension	0.000954	0.0126	CcSEcCtD
Ingenol Mebutate—Periorbital oedema—Betaxolol—hypertension	0.000939	0.0124	CcSEcCtD
Ingenol Mebutate—PRKCA—central nervous system—hypertension	0.000869	0.0176	CbGeAlD
Ingenol Mebutate—Application site pain—Furosemide—hypertension	0.000852	0.0113	CcSEcCtD
Ingenol Mebutate—Ulcer—Spironolactone—hypertension	0.000729	0.00965	CcSEcCtD
Ingenol Mebutate—Eye pain—Prazosin—hypertension	0.000685	0.00907	CcSEcCtD
Ingenol Mebutate—Eyelid oedema—Timolol—hypertension	0.000601	0.00796	CcSEcCtD
Ingenol Mebutate—Swelling—Felodipine—hypertension	0.000569	0.00754	CcSEcCtD
Ingenol Mebutate—Swelling—Metolazone—hypertension	0.000569	0.00754	CcSEcCtD
Ingenol Mebutate—Eye pain—Acebutolol—hypertension	0.000522	0.00692	CcSEcCtD
Ingenol Mebutate—Swelling—Eprosartan—hypertension	0.000513	0.0068	CcSEcCtD
Ingenol Mebutate—Ulcer—Nifedipine—hypertension	0.00051	0.00676	CcSEcCtD
Ingenol Mebutate—Eye pain—Amlodipine—hypertension	0.000487	0.00645	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Felodipine—hypertension	0.000449	0.00595	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Esmolol—hypertension	0.000438	0.00581	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Terazosin—hypertension	0.000432	0.00573	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Methyldopa—hypertension	0.000428	0.00568	CcSEcCtD
Ingenol Mebutate—Infestation—Methyldopa—hypertension	0.000428	0.00568	CcSEcCtD
Ingenol Mebutate—Ulcer—Captopril—hypertension	0.00042	0.00557	CcSEcCtD
Ingenol Mebutate—Swelling—Diltiazem—hypertension	0.000416	0.00551	CcSEcCtD
Ingenol Mebutate—Swelling—Carvedilol—hypertension	0.000412	0.00546	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Hydralazine—hypertension	0.000409	0.00542	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Quinapril—hypertension	0.000408	0.00541	CcSEcCtD
Ingenol Mebutate—Infestation—Quinapril—hypertension	0.000408	0.00541	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Pindolol—hypertension	0.000404	0.00535	CcSEcCtD
Ingenol Mebutate—Swelling—Fosinopril—hypertension	0.000402	0.00533	CcSEcCtD
Ingenol Mebutate—Eye pain—Doxazosin—hypertension	0.000398	0.00528	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Nadolol—hypertension	0.000389	0.00515	CcSEcCtD
Ingenol Mebutate—Eye pain—Nifedipine—hypertension	0.000388	0.00514	CcSEcCtD
Ingenol Mebutate—Erythema—Chlorothiazide—hypertension	0.000382	0.00506	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Guanfacine—hypertension	0.000382	0.00506	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Nicardipine—hypertension	0.00038	0.00504	CcSEcCtD
Ingenol Mebutate—Swelling—Valsartan—hypertension	0.000368	0.00488	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Terazosin—hypertension	0.000362	0.0048	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Acebutolol—hypertension	0.000353	0.00468	CcSEcCtD
Ingenol Mebutate—Eye disorder—Quinapril—hypertension	0.000343	0.00454	CcSEcCtD
Ingenol Mebutate—Swelling—Enalapril—hypertension	0.000341	0.00452	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Eprosartan—hypertension	0.000339	0.00449	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Nebivolol—hypertension	0.000333	0.00441	CcSEcCtD
Ingenol Mebutate—Eye disorder—Isradipine—hypertension	0.000331	0.00438	CcSEcCtD
Ingenol Mebutate—Eye disorder—Guanfacine—hypertension	0.000329	0.00436	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Amlodipine—hypertension	0.000329	0.00436	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Nisoldipine—hypertension	0.000329	0.00436	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Indapamide—hypertension	0.000328	0.00435	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Diltiazem—hypertension	0.000328	0.00435	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Carvedilol—hypertension	0.000325	0.00431	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Guanabenz—hypertension	0.000318	0.00422	CcSEcCtD
Ingenol Mebutate—Infestation—Guanabenz—hypertension	0.000318	0.00422	CcSEcCtD
Ingenol Mebutate—Swelling—Irbesartan—hypertension	0.000316	0.00419	CcSEcCtD
Ingenol Mebutate—Swelling—Hydrochlorothiazide—hypertension	0.000314	0.00416	CcSEcCtD
Ingenol Mebutate—Eye disorder—Terazosin—hypertension	0.000313	0.00414	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Metoprolol—hypertension	0.000309	0.0041	CcSEcCtD
Ingenol Mebutate—Swelling—Furosemide—hypertension	0.000308	0.00409	CcSEcCtD
Ingenol Mebutate—Erythema—Felodipine—hypertension	0.000302	0.00401	CcSEcCtD
Ingenol Mebutate—Eye pain—Betaxolol—hypertension	0.000298	0.00396	CcSEcCtD
Ingenol Mebutate—Swelling—Losartan—hypertension	0.000298	0.00394	CcSEcCtD
Ingenol Mebutate—Erythema—Esmolol—hypertension	0.000295	0.00391	CcSEcCtD
Ingenol Mebutate—Infestation—Propranolol—hypertension	0.000292	0.00387	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Propranolol—hypertension	0.000292	0.00387	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Olmesartan—hypertension	0.000289	0.00383	CcSEcCtD
Ingenol Mebutate—Eye disorder—Amlodipine—hypertension	0.000284	0.00376	CcSEcCtD
Ingenol Mebutate—Erythema—Labetalol—hypertension	0.000281	0.00373	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Clonidine—hypertension	0.000277	0.00367	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Diltiazem—hypertension	0.000275	0.00364	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Indapamide—hypertension	0.000275	0.00364	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Eplerenone—hypertension	0.000272	0.0036	CcSEcCtD
Ingenol Mebutate—Infestation—Eplerenone—hypertension	0.000272	0.0036	CcSEcCtD
Ingenol Mebutate—Infection—Methyldopa—hypertension	0.000271	0.0036	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Doxazosin—hypertension	0.000269	0.00357	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Enalapril—hypertension	0.000269	0.00356	CcSEcCtD
Ingenol Mebutate—Headache—Triamterene—hypertension	0.000268	0.00355	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Methyldopa—hypertension	0.000268	0.00355	CcSEcCtD
Ingenol Mebutate—Eye disorder—Guanabenz—hypertension	0.000267	0.00354	CcSEcCtD
Ingenol Mebutate—Eye disorder—Metoprolol—hypertension	0.000267	0.00354	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Nifedipine—hypertension	0.000262	0.00348	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Pindolol—hypertension	0.00026	0.00344	CcSEcCtD
Ingenol Mebutate—Infection—Quinapril—hypertension	0.000259	0.00343	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Quinapril—hypertension	0.000255	0.00338	CcSEcCtD
Ingenol Mebutate—Infection—Benazepril—hypertension	0.000255	0.00337	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Perindopril—hypertension	0.00025	0.00332	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Valsartan—hypertension	0.00025	0.00332	CcSEcCtD
Ingenol Mebutate—Infestation—Valsartan—hypertension	0.00025	0.00332	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Irbesartan—hypertension	0.00025	0.00331	CcSEcCtD
Ingenol Mebutate—Infestation—Olmesartan—hypertension	0.000249	0.0033	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Olmesartan—hypertension	0.000249	0.0033	CcSEcCtD
Ingenol Mebutate—Erythema—Guanabenz—hypertension	0.000249	0.00329	CcSEcCtD
Ingenol Mebutate—Infection—Nicardipine—hypertension	0.000248	0.00328	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Isradipine—hypertension	0.000246	0.00327	CcSEcCtD
Ingenol Mebutate—Eye pain—Timolol—hypertension	0.000244	0.00323	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Betaxolol—hypertension	0.000241	0.00319	CcSEcCtD
Ingenol Mebutate—Eye disorder—Diltiazem—hypertension	0.000237	0.00314	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Esmolol—hypertension	0.000236	0.00313	CcSEcCtD
Ingenol Mebutate—Infestation—Trandolapril—hypertension	0.000233	0.00308	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Trandolapril—hypertension	0.000233	0.00308	CcSEcCtD
Ingenol Mebutate—Headache—Hydroflumethiazide—hypertension	0.000233	0.00308	CcSEcCtD
Ingenol Mebutate—Eye disorder—Doxazosin—hypertension	0.000232	0.00308	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Telmisartan—hypertension	0.000229	0.00303	CcSEcCtD
Ingenol Mebutate—Infestation—Telmisartan—hypertension	0.000229	0.00303	CcSEcCtD
Ingenol Mebutate—Erythema—Propranolol—hypertension	0.000228	0.00303	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Acebutolol—hypertension	0.000227	0.00301	CcSEcCtD
Ingenol Mebutate—Eye disorder—Nifedipine—hypertension	0.000226	0.003	CcSEcCtD
Ingenol Mebutate—Headache—Ethacrynic acid—hypertension	0.000226	0.00299	CcSEcCtD
Ingenol Mebutate—Headache—Reserpine—hypertension	0.000226	0.00299	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Enalapril—hypertension	0.000225	0.00298	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Telmisartan—hypertension	0.000222	0.00294	CcSEcCtD
Ingenol Mebutate—Erythema—Indapamide—hypertension	0.000221	0.00293	CcSEcCtD
Ingenol Mebutate—Erythema—Diltiazem—hypertension	0.000221	0.00293	CcSEcCtD
Ingenol Mebutate—Headache—Fenoldopam—hypertension	0.000218	0.00289	CcSEcCtD
Ingenol Mebutate—Headache—Nebivolol—hypertension	0.000213	0.00282	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Amlodipine—hypertension	0.000212	0.00281	CcSEcCtD
Ingenol Mebutate—Erythema—Nifedipine—hypertension	0.000211	0.0028	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Perindopril—hypertension	0.00021	0.00278	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Irbesartan—hypertension	0.000209	0.00277	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Betaxolol—hypertension	0.000208	0.00275	CcSEcCtD
Ingenol Mebutate—Infestation—Betaxolol—hypertension	0.000208	0.00275	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Hydrochlorothiazide—hypertension	0.000207	0.00275	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Betaxolol—hypertension	0.000202	0.00267	CcSEcCtD
Ingenol Mebutate—Infection—Guanabenz—hypertension	0.000202	0.00267	CcSEcCtD
Ingenol Mebutate—Headache—Torasemide—hypertension	0.0002	0.00266	CcSEcCtD
Ingenol Mebutate—Eye disorder—Clonidine—hypertension	0.0002	0.00265	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Guanabenz—hypertension	0.000199	0.00264	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Metoprolol—hypertension	0.000199	0.00264	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Timolol—hypertension	0.000197	0.00261	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Losartan—hypertension	0.000197	0.00261	CcSEcCtD
Ingenol Mebutate—Eye disorder—Trandolapril—hypertension	0.000195	0.00259	CcSEcCtD
Ingenol Mebutate—Headache—Chlorothiazide—hypertension	0.000195	0.00259	CcSEcCtD
Ingenol Mebutate—Eye disorder—Telmisartan—hypertension	0.000192	0.00254	CcSEcCtD
Ingenol Mebutate—Headache—Chlorthalidone—hypertension	0.000191	0.00254	CcSEcCtD
Ingenol Mebutate—Headache—Bumetanide—hypertension	0.00019	0.00252	CcSEcCtD
Ingenol Mebutate—Headache—Prazosin—hypertension	0.00019	0.00252	CcSEcCtD
Ingenol Mebutate—Erythema—Clonidine—hypertension	0.000186	0.00247	CcSEcCtD
Ingenol Mebutate—Infection—Propranolol—hypertension	0.000185	0.00245	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Propranolol—hypertension	0.000183	0.00242	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Lisinopril—hypertension	0.000183	0.00242	CcSEcCtD
Ingenol Mebutate—Erythema—Enalapril—hypertension	0.000181	0.0024	CcSEcCtD
Ingenol Mebutate—Eye disorder—Perindopril—hypertension	0.000181	0.0024	CcSEcCtD
Ingenol Mebutate—Headache—Bepridil—hypertension	0.00018	0.00238	CcSEcCtD
Ingenol Mebutate—Infection—Indapamide—hypertension	0.000179	0.00237	CcSEcCtD
Ingenol Mebutate—Infection—Diltiazem—hypertension	0.000179	0.00237	CcSEcCtD
Ingenol Mebutate—Erythema—Telmisartan—hypertension	0.000179	0.00237	CcSEcCtD
Ingenol Mebutate—Headache—Penbutolol—hypertension	0.000178	0.00236	CcSEcCtD
Ingenol Mebutate—Infection—Carvedilol—hypertension	0.000177	0.00235	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Indapamide—hypertension	0.000177	0.00234	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Diltiazem—hypertension	0.000177	0.00234	CcSEcCtD
Ingenol Mebutate—Eye disorder—Furosemide—hypertension	0.000176	0.00233	CcSEcCtD
Ingenol Mebutate—Infection—Doxazosin—hypertension	0.000175	0.00233	CcSEcCtD
Ingenol Mebutate—Eye disorder—Betaxolol—hypertension	0.000174	0.00231	CcSEcCtD
Ingenol Mebutate—Headache—Candesartan—hypertension	0.000174	0.0023	CcSEcCtD
Ingenol Mebutate—Infection—Fosinopril—hypertension	0.000173	0.0023	CcSEcCtD
Ingenol Mebutate—Infection—Eplerenone—hypertension	0.000172	0.00228	CcSEcCtD
Ingenol Mebutate—Headache—Methyldopa—hypertension	0.000171	0.00227	CcSEcCtD
Ingenol Mebutate—Infection—Verapamil—hypertension	0.00017	0.00226	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Eplerenone—hypertension	0.00017	0.00225	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Nifedipine—hypertension	0.000169	0.00224	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Ramipril—hypertension	0.000169	0.00223	CcSEcCtD
Ingenol Mebutate—Erythema—Perindopril—hypertension	0.000169	0.00223	CcSEcCtD
Ingenol Mebutate—Headache—Hydralazine—hypertension	0.000168	0.00223	CcSEcCtD
Ingenol Mebutate—Headache—Amiloride—hypertension	0.000168	0.00223	CcSEcCtD
Ingenol Mebutate—Erythema—Irbesartan—hypertension	0.000168	0.00223	CcSEcCtD
Ingenol Mebutate—Erythema—Hydrochlorothiazide—hypertension	0.000167	0.00221	CcSEcCtD
Ingenol Mebutate—Headache—Pindolol—hypertension	0.000166	0.0022	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Timolol—hypertension	0.000165	0.00218	CcSEcCtD
Ingenol Mebutate—Erythema—Furosemide—hypertension	0.000164	0.00217	CcSEcCtD
Ingenol Mebutate—Headache—Quinapril—hypertension	0.000163	0.00216	CcSEcCtD
Ingenol Mebutate—Erythema—Betaxolol—hypertension	0.000162	0.00215	CcSEcCtD
Ingenol Mebutate—Headache—Benazepril—hypertension	0.000161	0.00213	CcSEcCtD
Ingenol Mebutate—Infection—Valsartan—hypertension	0.000159	0.0021	CcSEcCtD
Ingenol Mebutate—Erythema—Losartan—hypertension	0.000158	0.0021	CcSEcCtD
Ingenol Mebutate—Infection—Olmesartan—hypertension	0.000158	0.00209	CcSEcCtD
Ingenol Mebutate—Headache—Isradipine—hypertension	0.000157	0.00209	CcSEcCtD
Ingenol Mebutate—Headache—Guanfacine—hypertension	0.000157	0.00208	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Valsartan—hypertension	0.000156	0.00207	CcSEcCtD
Ingenol Mebutate—Headache—Nicardipine—hypertension	0.000156	0.00207	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Olmesartan—hypertension	0.000156	0.00206	CcSEcCtD
Ingenol Mebutate—Headache—Metolazone—hypertension	0.000155	0.00205	CcSEcCtD
Ingenol Mebutate—Headache—Felodipine—hypertension	0.000155	0.00205	CcSEcCtD
Ingenol Mebutate—Headache—Spironolactone—hypertension	0.000154	0.00204	CcSEcCtD
Ingenol Mebutate—Infection—Clonidine—hypertension	0.000151	0.002	CcSEcCtD
Ingenol Mebutate—Headache—Esmolol—hypertension	0.000151	0.002	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Clonidine—hypertension	0.000149	0.00198	CcSEcCtD
Ingenol Mebutate—Headache—Terazosin—hypertension	0.000149	0.00197	CcSEcCtD
Ingenol Mebutate—Infection—Trandolapril—hypertension	0.000147	0.00195	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Trandolapril—hypertension	0.000145	0.00193	CcSEcCtD
Ingenol Mebutate—Headache—Acebutolol—hypertension	0.000145	0.00192	CcSEcCtD
Ingenol Mebutate—Infection—Telmisartan—hypertension	0.000145	0.00192	CcSEcCtD
Ingenol Mebutate—Headache—Labetalol—hypertension	0.000144	0.00191	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Telmisartan—hypertension	0.000143	0.00189	CcSEcCtD
Ingenol Mebutate—Eye disorder—Timolol—hypertension	0.000142	0.00189	CcSEcCtD
Ingenol Mebutate—Headache—Eprosartan—hypertension	0.000139	0.00185	CcSEcCtD
Ingenol Mebutate—Infection—Irbesartan—hypertension	0.000136	0.00181	CcSEcCtD
Ingenol Mebutate—Erythema—Ramipril—hypertension	0.000136	0.0018	CcSEcCtD
Ingenol Mebutate—Headache—Amlodipine—hypertension	0.000135	0.00179	CcSEcCtD
Ingenol Mebutate—Headache—Nisoldipine—hypertension	0.000135	0.00179	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Perindopril—hypertension	0.000135	0.00179	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Irbesartan—hypertension	0.000134	0.00178	CcSEcCtD
Ingenol Mebutate—Erythema—Timolol—hypertension	0.000133	0.00176	CcSEcCtD
Ingenol Mebutate—Infection—Betaxolol—hypertension	0.000132	0.00174	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Furosemide—hypertension	0.000131	0.00174	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Betaxolol—hypertension	0.00013	0.00172	CcSEcCtD
Ingenol Mebutate—Infection—Losartan—hypertension	0.000128	0.0017	CcSEcCtD
Ingenol Mebutate—Headache—Metoprolol—hypertension	0.000127	0.00168	CcSEcCtD
Ingenol Mebutate—Headache—Guanabenz—hypertension	0.000127	0.00168	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Losartan—hypertension	0.000127	0.00168	CcSEcCtD
Ingenol Mebutate—Erythema—Lisinopril—hypertension	0.000123	0.00163	CcSEcCtD
Ingenol Mebutate—Headache—Diltiazem—hypertension	0.000113	0.0015	CcSEcCtD
Ingenol Mebutate—Headache—Indapamide—hypertension	0.000113	0.0015	CcSEcCtD
Ingenol Mebutate—Headache—Carvedilol—hypertension	0.000112	0.00148	CcSEcCtD
Ingenol Mebutate—Headache—Doxazosin—hypertension	0.000111	0.00147	CcSEcCtD
Ingenol Mebutate—Headache—Fosinopril—hypertension	0.000109	0.00145	CcSEcCtD
Ingenol Mebutate—Headache—Eplerenone—hypertension	0.000109	0.00144	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Ramipril—hypertension	0.000109	0.00144	CcSEcCtD
Ingenol Mebutate—Headache—Nifedipine—hypertension	0.000108	0.00143	CcSEcCtD
Ingenol Mebutate—Infection—Timolol—hypertension	0.000107	0.00142	CcSEcCtD
Ingenol Mebutate—Headache—Verapamil—hypertension	0.000107	0.00142	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Timolol—hypertension	0.000106	0.00141	CcSEcCtD
Ingenol Mebutate—Headache—Valsartan—hypertension	0.0001	0.00132	CcSEcCtD
Ingenol Mebutate—Infection—Lisinopril—hypertension	9.97e-05	0.00132	CcSEcCtD
Ingenol Mebutate—Headache—Olmesartan—hypertension	9.95e-05	0.00132	CcSEcCtD
Ingenol Mebutate—Headache—Clonidine—hypertension	9.53e-05	0.00126	CcSEcCtD
Ingenol Mebutate—Headache—Trandolapril—hypertension	9.29e-05	0.00123	CcSEcCtD
Ingenol Mebutate—Headache—Enalapril—hypertension	9.26e-05	0.00123	CcSEcCtD
Ingenol Mebutate—Headache—Telmisartan—hypertension	9.13e-05	0.00121	CcSEcCtD
Ingenol Mebutate—Headache—Captopril—hypertension	8.88e-05	0.00118	CcSEcCtD
Ingenol Mebutate—Headache—Perindopril—hypertension	8.62e-05	0.00114	CcSEcCtD
Ingenol Mebutate—Headache—Irbesartan—hypertension	8.59e-05	0.00114	CcSEcCtD
Ingenol Mebutate—Headache—Hydrochlorothiazide—hypertension	8.52e-05	0.00113	CcSEcCtD
Ingenol Mebutate—Headache—Furosemide—hypertension	8.38e-05	0.00111	CcSEcCtD
Ingenol Mebutate—Headache—Betaxolol—hypertension	8.3e-05	0.0011	CcSEcCtD
Ingenol Mebutate—Headache—Losartan—hypertension	8.08e-05	0.00107	CcSEcCtD
Ingenol Mebutate—Headache—Ramipril—hypertension	6.93e-05	0.000919	CcSEcCtD
Ingenol Mebutate—Headache—Timolol—hypertension	6.78e-05	0.000898	CcSEcCtD
Ingenol Mebutate—Headache—Lisinopril—hypertension	6.29e-05	0.000833	CcSEcCtD
Ingenol Mebutate—PRKCA—Signaling by GPCR—PRKCB—hypertension	4.7e-06	2.78e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—F2—hypertension	4.7e-06	2.78e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—AKT1—hypertension	4.69e-06	2.77e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—VEGFA—hypertension	4.69e-06	2.77e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CDKN1A—hypertension	4.69e-06	2.77e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—COMT—hypertension	4.68e-06	2.76e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—PTEN—hypertension	4.68e-06	2.76e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—EP300—hypertension	4.67e-06	2.76e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ADRBK1—hypertension	4.67e-06	2.76e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CRP—hypertension	4.66e-06	2.75e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—MAPK8—hypertension	4.64e-06	2.74e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CNR1—hypertension	4.64e-06	2.74e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CCR5—hypertension	4.62e-06	2.73e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PRKCD—hypertension	4.62e-06	2.73e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PPARGC1A—hypertension	4.62e-06	2.72e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—GNB3—hypertension	4.62e-06	2.72e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—HMOX1—hypertension	4.6e-06	2.71e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CALM2—hypertension	4.59e-06	2.71e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—MAPK8—hypertension	4.57e-06	2.7e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CALM1—hypertension	4.57e-06	2.7e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—MYC—hypertension	4.55e-06	2.69e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—AKT2—hypertension	4.53e-06	2.68e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CAT—hypertension	4.53e-06	2.68e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—HTR7—hypertension	4.52e-06	2.67e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—DRD2—hypertension	4.52e-06	2.67e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—EP300—hypertension	4.52e-06	2.67e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—MTHFR—hypertension	4.52e-06	2.67e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—GNAS—hypertension	4.5e-06	2.65e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PTPN1—hypertension	4.48e-06	2.64e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—GCG—hypertension	4.48e-06	2.64e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—EP300—hypertension	4.46e-06	2.63e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—POMC—hypertension	4.41e-06	2.6e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—APOB—hypertension	4.4e-06	2.6e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PDGFB—hypertension	4.4e-06	2.6e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—SRC—hypertension	4.4e-06	2.59e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—KL—hypertension	4.39e-06	2.59e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NOTCH2—hypertension	4.39e-06	2.59e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CDKN1A—hypertension	4.39e-06	2.59e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—INS—hypertension	4.38e-06	2.59e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—PTEN—hypertension	4.38e-06	2.58e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—FGFR1—hypertension	4.38e-06	2.58e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by Wnt—AKT1—hypertension	4.35e-06	2.57e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—SRC—hypertension	4.34e-06	2.56e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NGFR—hypertension	4.31e-06	2.54e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CCL2—hypertension	4.31e-06	2.54e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ITGAV—hypertension	4.31e-06	2.54e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—HIF1A—hypertension	4.31e-06	2.54e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—TGFB1—hypertension	4.31e-06	2.54e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—KNG1—hypertension	4.3e-06	2.54e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PRKCB—hypertension	4.3e-06	2.54e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—POMC—hypertension	4.28e-06	2.53e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—GSTM1—hypertension	4.28e-06	2.53e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—ICAM1—hypertension	4.28e-06	2.53e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—AGTR1—hypertension	4.27e-06	2.52e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PRL—hypertension	4.27e-06	2.52e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IGF1—hypertension	4.24e-06	2.5e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—AKT2—hypertension	4.24e-06	2.5e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CALM1—hypertension	4.22e-06	2.49e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—EGFR—hypertension	4.22e-06	2.49e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—STK11—hypertension	4.21e-06	2.49e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—HDAC1—hypertension	4.21e-06	2.49e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—APOE—hypertension	4.21e-06	2.48e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—LPL—hypertension	4.2e-06	2.48e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—CCL2—hypertension	4.19e-06	2.47e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—NOTCH1—hypertension	4.18e-06	2.47e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CXCL10—hypertension	4.18e-06	2.46e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—EP300—hypertension	4.17e-06	2.46e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CAV1—hypertension	4.17e-06	2.46e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PLG—hypertension	4.16e-06	2.46e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—APOA1—hypertension	4.16e-06	2.45e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—RHOA—hypertension	4.16e-06	2.45e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—AKT2—hypertension	4.12e-06	2.43e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—ADCY5—hypertension	4.12e-06	2.43e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—PIK3R1—hypertension	4.11e-06	2.43e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—GPX1—hypertension	4.1e-06	2.42e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—MYC—hypertension	4.07e-06	2.4e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CYP1A1—hypertension	4.06e-06	2.4e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—SRC—hypertension	4.06e-06	2.4e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ADRB2—hypertension	4.05e-06	2.39e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SERPINE1—hypertension	4.03e-06	2.38e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PRKCE—hypertension	4e-06	2.36e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CD36—hypertension	3.99e-06	2.36e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PDGFA—hypertension	3.95e-06	2.33e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—VAV3—hypertension	3.95e-06	2.33e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—PPARG—hypertension	3.95e-06	2.33e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—FOS—hypertension	3.92e-06	2.31e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—NOS2—hypertension	3.92e-06	2.31e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—MYC—hypertension	3.92e-06	2.31e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TGFBR2—hypertension	3.9e-06	2.3e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—FGF2—hypertension	3.9e-06	2.3e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—RHOA—hypertension	3.88e-06	2.29e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—NOTCH1—hypertension	3.88e-06	2.29e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—GNB3—hypertension	3.86e-06	2.28e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—EGFR—hypertension	3.85e-06	2.27e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PIK3R1—hypertension	3.84e-06	2.27e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NOS3—hypertension	3.84e-06	2.27e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—AVP—hypertension	3.81e-06	2.25e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—EGFR—hypertension	3.8e-06	2.24e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—MTHFR—hypertension	3.78e-06	2.23e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—RHOA—hypertension	3.78e-06	2.23e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—AKT2—hypertension	3.76e-06	2.22e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—GNAS—hypertension	3.76e-06	2.22e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—PIK3R1—hypertension	3.74e-06	2.21e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PPARA—hypertension	3.71e-06	2.19e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—APOB—hypertension	3.68e-06	2.17e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PTK2—hypertension	3.67e-06	2.16e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—CXCL8—hypertension	3.65e-06	2.15e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—MYC—hypertension	3.64e-06	2.15e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—TGFB1—hypertension	3.63e-06	2.14e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—EDN1—hypertension	3.62e-06	2.14e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—RELA—hypertension	3.62e-06	2.13e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—AGT—hypertension	3.6e-06	2.12e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CCL5—hypertension	3.59e-06	2.12e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—INS—hypertension	3.59e-06	2.12e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—EGFR—hypertension	3.56e-06	2.1e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—SERPINE1—hypertension	3.56e-06	2.1e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MTOR—hypertension	3.55e-06	2.09e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—TP53—hypertension	3.54e-06	2.09e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CALM1—hypertension	3.54e-06	2.09e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—APOE—hypertension	3.52e-06	2.08e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—LPL—hypertension	3.51e-06	2.07e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CAV1—hypertension	3.49e-06	2.06e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—H2AFX—hypertension	3.49e-06	2.06e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PDGFRB—hypertension	3.48e-06	2.06e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—RPS6KB1—hypertension	3.48e-06	2.06e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—APOA1—hypertension	3.48e-06	2.06e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—AKT2—hypertension	3.47e-06	2.05e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—FGF2—hypertension	3.46e-06	2.04e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ADCY5—hypertension	3.44e-06	2.03e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PRKCG—hypertension	3.42e-06	2.02e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PIK3R1—hypertension	3.41e-06	2.01e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CXCL8—hypertension	3.41e-06	2.01e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ITGB3—hypertension	3.39e-06	2e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—YWHAZ—hypertension	3.37e-06	1.99e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—TP53—hypertension	3.34e-06	1.97e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NGF—hypertension	3.33e-06	1.96e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SPP1—hypertension	3.33e-06	1.96e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—CXCL8—hypertension	3.31e-06	1.96e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—SERPINE1—hypertension	3.3e-06	1.95e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—AKT1—hypertension	3.29e-06	1.94e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—BCL2—hypertension	3.29e-06	1.94e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—IL6—hypertension	3.24e-06	1.91e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CCR5—hypertension	3.24e-06	1.91e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PRKCD—hypertension	3.24e-06	1.91e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—RELA—hypertension	3.21e-06	1.9e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—FGF2—hypertension	3.2e-06	1.89e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—RHOA—hypertension	3.18e-06	1.88e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—HTR2A—hypertension	3.17e-06	1.87e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—C3—hypertension	3.16e-06	1.87e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PIK3R1—hypertension	3.15e-06	1.86e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—NOS3—hypertension	3.15e-06	1.86e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—MTOR—hypertension	3.15e-06	1.86e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MMP9—hypertension	3.08e-06	1.82e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PDGFB—hypertension	3.08e-06	1.82e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CDKN1A—hypertension	3.07e-06	1.81e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PPARG—hypertension	3.07e-06	1.81e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PTEN—hypertension	3.07e-06	1.81e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—FGFR1—hypertension	3.06e-06	1.81e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—POMC—hypertension	3.03e-06	1.79e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—HIF1A—hypertension	3.02e-06	1.78e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—INS—hypertension	3.01e-06	1.78e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—AGT—hypertension	3.01e-06	1.77e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MAPK8—hypertension	3e-06	1.77e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—AKT1—hypertension	2.99e-06	1.77e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—AKT1—hypertension	2.99e-06	1.76e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IL6—hypertension	2.96e-06	1.75e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CALM1—hypertension	2.96e-06	1.74e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—LEP—hypertension	2.95e-06	1.74e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—APOE—hypertension	2.95e-06	1.74e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—EP300—hypertension	2.92e-06	1.73e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—IL6—hypertension	2.92e-06	1.72e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CAV1—hypertension	2.92e-06	1.72e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—APOA1—hypertension	2.91e-06	1.72e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—MTOR—hypertension	2.91e-06	1.72e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IL1B—hypertension	2.9e-06	1.71e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—KDR—hypertension	2.89e-06	1.7e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PTGS2—hypertension	2.88e-06	1.7e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SRC—hypertension	2.84e-06	1.68e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—FN1—hypertension	2.78e-06	1.64e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—F2—hypertension	2.78e-06	1.64e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PRKCB—hypertension	2.78e-06	1.64e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—VEGFA—hypertension	2.77e-06	1.63e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—ALB—hypertension	2.76e-06	1.63e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—IL6—hypertension	2.73e-06	1.61e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—AKT1—hypertension	2.73e-06	1.61e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CDKN1A—hypertension	2.73e-06	1.61e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PTEN—hypertension	2.72e-06	1.61e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NOTCH1—hypertension	2.72e-06	1.6e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—AKT1—hypertension	2.72e-06	1.6e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—AKT1—hypertension	2.69e-06	1.59e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—MAPK8—hypertension	2.66e-06	1.57e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PIK3R1—hypertension	2.64e-06	1.56e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—NOS3—hypertension	2.64e-06	1.56e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—EP300—hypertension	2.6e-06	1.53e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MYC—hypertension	2.55e-06	1.5e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TGFB1—hypertension	2.54e-06	1.5e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—POMC—hypertension	2.53e-06	1.49e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—SRC—hypertension	2.53e-06	1.49e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—AKT1—hypertension	2.52e-06	1.49e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CDKN1A—hypertension	2.52e-06	1.49e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—INS—hypertension	2.52e-06	1.49e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PTEN—hypertension	2.51e-06	1.48e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—EGFR—hypertension	2.49e-06	1.47e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CCL2—hypertension	2.48e-06	1.46e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IGF1—hypertension	2.43e-06	1.44e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—AKT2—hypertension	2.43e-06	1.44e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—EGFR—hypertension	2.42e-06	1.43e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PTGS2—hypertension	2.41e-06	1.42e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—EP300—hypertension	2.4e-06	1.41e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—SRC—hypertension	2.33e-06	1.38e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SERPINE1—hypertension	2.31e-06	1.36e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—MYC—hypertension	2.25e-06	1.33e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—FGF2—hypertension	2.24e-06	1.32e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—RHOA—hypertension	2.23e-06	1.32e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—EGFR—hypertension	2.21e-06	1.31e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PIK3R1—hypertension	2.21e-06	1.3e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NOS3—hypertension	2.21e-06	1.3e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PTEN—hypertension	2.11e-06	1.24e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TP53—hypertension	2.09e-06	1.23e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—MYC—hypertension	2.09e-06	1.23e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—TGFB1—hypertension	2.08e-06	1.23e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—RELA—hypertension	2.08e-06	1.23e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—EGFR—hypertension	2.04e-06	1.21e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MTOR—hypertension	2.04e-06	1.2e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—EP300—hypertension	2.01e-06	1.19e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CXCL8—hypertension	1.96e-06	1.16e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IL6—hypertension	1.91e-06	1.13e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—AKT1—hypertension	1.89e-06	1.12e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—IL6—hypertension	1.86e-06	1.1e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MMP9—hypertension	1.77e-06	1.05e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—AKT1—hypertension	1.77e-06	1.04e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CDKN1A—hypertension	1.76e-06	1.04e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PTEN—hypertension	1.76e-06	1.04e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MAPK8—hypertension	1.72e-06	1.02e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—AKT1—hypertension	1.72e-06	1.01e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IL6—hypertension	1.7e-06	1e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—EP300—hypertension	1.68e-06	9.91e-06	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SRC—hypertension	1.63e-06	9.64e-06	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—VEGFA—hypertension	1.59e-06	9.38e-06	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—IL6—hypertension	1.57e-06	9.27e-06	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—AKT1—hypertension	1.57e-06	9.26e-06	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—AKT1—hypertension	1.56e-06	9.21e-06	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MYC—hypertension	1.46e-06	8.63e-06	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TGFB1—hypertension	1.46e-06	8.61e-06	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—AKT1—hypertension	1.45e-06	8.55e-06	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—EGFR—hypertension	1.43e-06	8.45e-06	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—AKT1—hypertension	1.21e-06	7.16e-06	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TP53—hypertension	1.2e-06	7.09e-06	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IL6—hypertension	1.1e-06	6.49e-06	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—AKT1—hypertension	1.01e-06	5.99e-06	CbGpPWpGaD
